2097333-76-9 Usage
Uses
Used in Pharmaceutical Research and Development:
(3aR,8aS)-2-(5-(trifluoromethyl)pyridin-2-yl)-8,8a-dihydro-3aH-indeno[1,2-d]oxazole is used as a compound of interest for pharmaceutical research and development due to its unique structural features and potential biological activities. The presence of the trifluoromethyl group and the heterocyclic nature of the molecule may contribute to its potential as a lead compound in the discovery of new drugs or therapeutic agents.
Further studies and investigations are required to fully understand the properties and potential uses of this chemical, as its complex structure and the presence of the trifluoromethyl group may offer novel avenues for medicinal chemistry and drug design.
Check Digit Verification of cas no
The CAS Registry Mumber 2097333-76-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 2,0,9,7,3,3 and 3 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 2097333-76:
(9*2)+(8*0)+(7*9)+(6*7)+(5*3)+(4*3)+(3*3)+(2*7)+(1*6)=179
179 % 10 = 9
So 2097333-76-9 is a valid CAS Registry Number.
2097333-76-9Relevant academic research and scientific papers
Enantioselective Construction of Trifluoromethoxylated Stereogenic Centers by a Nickel-Catalyzed Asymmetric Suzuki–Miyaura Coupling of Secondary Benzyl Bromides
Huang, Weichen,Wan, Xiaolong,Shen, Qilong
supporting information, p. 11986 - 11989 (2017/09/20)
Trifluoromethoxy-substituted stereogenic centers can be constructed with high enantioselectivity by a nickel-catalyzed Suzuki–Miyaura coupling of readily available α-bromobenzyl trifluoromethyl ethers with a variety of aryl pinacol boronates. The coupling proceeds under mild reaction conditions, and a variety of common functional groups, such as fluoride, chloride, bromide, ester, enolizable ketone, nitro, cyano, amino, and vinyl moieties, were well tolerated. Furthermore, the reaction can be easily scaled up to gram quantities without a decrease in enantioselectivity.
